AgingResearch.News
Journal of the American Heart Association

Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment

By Jens Kæstel Skov, Tor Skibsted Clemmensen, Christopher G. Scott, Show 4 more authorsMartha A. Grogan
Study in peopleBiomarkers
Paper

The paper

Jens Kæstel Skov, Tor Skibsted Clemmensen, Christopher G. Scott, Show 4 more authorsMartha A. Grogan

Aarhus University; Mayo Clinic

Journal of the American Heart Association, 7 Aug 2026

doi.org/10.1161/jaha.125.048585PubMed 42568056

Related